A Phase 3b Open-label Study Evaluating the Safety of Elexacaftor/Tezacaftor/Ivacaftor Combination Therapy in Cystic Fibrosis Subjects - VBX19-445-115

Project Details

StatusActive
Effective start/end date26/09/198/09/21

Funding

  • Vertex